PITX2 and Axenfeld-Rieger syndrome: Similarly, biochemical analyses of human ARS-causing mutations revealed severe ARS mutations that completely disrupted DNA binding activity and significantly decreased the transactivation activity of Pitx2 (Kozlowski and Walter, 2000; Priston et al., 2001; Espinoza et al., 2002).